Regulation of activity of the transcription factor GATA-1 by acetylation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DNA. A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p, PCAF, TAF(II)250 and p300/CBP. These acetyltransferases also modify certain transcription factors (TFIIEbeta, TFIIF, EKLF and p53). GATA-1 is an important transcription factor in the haematopoietic lineage and is essential for terminal differentiation of erythrocytes and megakaryocytes. It is associated in vivo with the acetyltransferase p300/CBP. Here we report that GATA-1 is acetylated in vitro by p300. This significantly increases the amount of GATA-1 bound to DNA and alters the mobility of GATA-1-DNA complexes, suggestive of a conformational change in GATA-1. GATA-1 is also acetylated in vivo and acetylation directly stimulates GATA-1-dependent transcription. Mutagenesis of important acetylated residues shows that there is a relationship between the acetylation and in vivo function of GATA-1. We propose that acetylation of transcription factors can alter interactions between these factors and DNA and among different transcription factors, and is an integral part of transcription and differentiation processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBP acetylates GATA-1 at two highly conserved lysine-rich motifs near each of the two zinc fingers (10, 27).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [10]
In the citing paper
“The basic tail of the GATA-1 CF has been shown to undergo a number of post-translational modifications.”
From Molecular Analysis of the Interaction between the Hematopoietic Master Transcription Factors GATA-1 and PU.1 (2006) · cites this paper as [34]
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Self-citationHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“gif" NDATA ITEM> ]> Modification of histones, DNA-binding proteins found in chromatin, by addition of acetyl groups occurs to a greater degree when the histones are associated with transcriptionally active DN”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 1×
“These acetyltransferases also modify certain transcription factors (TFIIEβ, TFIIF, EKLF and p53”
BackgroundThe CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,640 · cited 1×
“A breakthrough in understanding how this acetylation is mediated was the discovery that various transcriptional co-activator proteins have intrinsic histone acetyltransferase activity (for example, Gcn5p”
BackgroundA p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Self-citationPevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308 · cited 1×
“and is essential for terminal differentiation of erythrocytes and megakaryocyte”
BackgroundA direct link between core histone acetylation and transcriptionally active chromatin.
Hebbes, T. R., Thorne, A. W., & Crane-Robinson, C. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02956.x · Cited by 923
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884 · cited 1×
“GATA-1 is an important transcription factor in the haematopoietic lineag”
BackgroundThe TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity
Mizzen, C. A., Yang, X.-J., Kokubo, T., Brownell, J. E., Bannister, A. J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S. L., Kouzarides, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81821-8 · Cited by 727
Self-citation
Cited by
Items 401–500 of 708
Cross Talk between Retinoic Acid Signaling and Transcription Factor GATA-2
Tsuzuki, S., Kitajima, K., Nakano, T., Glasow, A., Zelent, A., & Enver, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6824-6836.2004 · Cited by 51
“The fact that GATA factors are known to be acetylated raises the possibility that these modifications could be similarly regulated (1, 22).”
BackgroundTranscriptional Regulation of Pro-apoptotic Protein Kinase Cδ
Jin, H., Kanthasamy, A., Anantharam, V., Rana, A., & Kanthasamy, A. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203687 · Cited by 47
Lü, J., Qu, S., Yao, B., Xu, Y., Jin, Y., Shi, K., Shui, Y., Pan, S., Chen, L., & Ma, C. (2016) · Oncotarget · doi:10.18632/oncotarget.9650 · Cited by 44
“In addition to histones, many non-histone proteins, including transcription factors such as p53, GATA-1 and Runx2, have been identified as substrates of acetyltransferases [26-28].”
BackgroundNarayanan, K., Srinivas, R., Peterson, M. C., Ramachandran, A., Hao, J. J., Thimmapaya, B., Scherer, P. E., & George, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403511200 · Cited by 45
Granja, A. G., Sánchez, E. G., Sabina, P., Fresno, M., & Revilla, Y. (2008) · Journal of Virology · doi:10.1128/jvi.01663-08 · Cited by 49
“We thank Neil D. Perkins for the generous gift of GAL4-p300 constructs.”
InfluentialNarendja, F. M., Davis, M. A., & Hynes, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6523 · Cited by 43
“The action of acetyltransferases may play a role in the local disruption of nucleosomes since an association of GATA-1 and NF-Y with acetyltransferases p300/CBP has been shown (8, 38).”
BackgroundThe homeodomain-containing proteins
Chariot, A., GIELEN, J. E., Merville, M.-P., & Bours, V. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00234-8 · Cited by 43
“TFIIH [51], p53 [52], EKLF [53], GATA-1 [54], and dTCF”
BackgroundEpigenetik – ein Epizentrum der Genregulation: Histone und histonmodifizierende Enzyme
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie · doi:10.1002/ange.200461346 · Cited by 47
Histone deacetylase inhibitors: a patent review (2009 – 2011)
Carafa, V., Miceli, M., Altucci, L., & Nebbioso, A. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.736493 · Cited by 42
Kutluay, S. B., DeVos, S. L., Klomp, J. E., & Triezenberg, S. J. (2009) · Journal of Virology · doi:10.1128/jvi.02349-08 · Cited by 43
“A p300 expression plasmid, pCI-FLAG-p300, was provided by Yoshihiro Nakatani ( 5 ).”
MethodAmin, R., Franz‐Wachtel, M., Tiffert, Y., Heberer, M., Meky, M., Ahmed, Y., Matthews, A., Krysenko, S., Jakobi, M., Hinder, M., et al. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00038 · Cited by 45
“…Biosciences | www.frontiersin.org 10 August 2016 | Volume 3 | Article 38 Lysine acetylation of proteins was first discovered in eukaryotes and best characterized for histones (Waterborg, 2001) and eukaryotic transcription factors (Boyes et al., 1998; Marzio et al., 2000; Furia et al., 2002).”
BackgroundMethodRole of chromatin in HIV-1 transcriptional regulation
Lint, C. M. V. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)48005-1 · Cited by 45
In vivo repression of an erythroid‐specific gene by distinct corepressor complexes
RIETVELD, L. E. G., Caldenhoven, E., & Stunnenberg, H. G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.6.1389 · Cited by 53
Shigeno, K., Yoshida, H., Pan, L., Luo, J. M., Fujisawa, S., Naito, K., Nakamura, S., Shinjo, K., Takeshita, A., Ohno, R., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00442-7 · Cited by 41
“1 or GATA-1 [12–15].”
Ho, P., Gupta, P. K., Tsui, Y.-C., Ha, S. G., Huq, M. D. M., & Wei, L. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.07.001 · Cited by 45
Abnormal histone acetylase and deacetylase expression and function in lung inflammation
Adcock, I. M., & Lee, K. Y. (2006) · Inflammation Research · doi:10.1007/s00011-006-0081-1 · Cited by 42
“[52] Boyes J, Byfield P, Nakatani Y, Ogryzko V.”
BackgroundInglis, D. O., & Johnson, A. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8669-8680.2002 · Cited by 49
“cerevisiae protein, C albicans Ash1p has three potential consensus sites for phosphorylation by Cdc28/CDK (1) and two consensus sites in the zinc finger for acetylation, a modification that alters the activity of the related GATA-1 transcriptional regulator in mammals (3).”
BackgroundBiological role of p300 in cardiac myocytes
Yanazume, T., Morimoto, T., Wada, H., Kawamura, T., & Hasegawa, K. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024132217870 · Cited by 44
“The HAT activity of p300/CBP is hypothesized to promote a locally ‘open’ and transcriptionally active chromatin configuration. p300 can acetylate not only histones but also certain transcriptional factors such as GATA-1 [38], p53 [39], other coactivators (ACTR) [40], basal transcription factors (TFIIEβ, TFIIF) [41], s…”
A Putative Silencer Element in the IL-5 Gene Recognized by Bcl6
Arima, M., Toyama, H., Ichii, H., Kojima, S., Okada, S., Hatano, M., Cheng, G., Kubo, M., Fukuda, T., & Tokuhisa, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.829 · Cited by 42
“A zinc fingertype transcription factor, GATA-1, increases its binding activity to the target DNA sequence by acetylation of lysine residues in the zinc finger domain (48).”
BackgroundOsborne, A. R., Zhang, H., Yang, W., Seto, E., & Blanck, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6495-6506.2001 · Cited by 41
“, transcription factors and components of the RNA polymerase II holoenzyme) are substrates for acetylation (8, 18, 22, 23, 37, 66), which may in turn affect their abilities to facilitate transcriptional activation.”
BackgroundMethodInfluentialPalani, S., & Sarkar, C. A. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120600 · Cited by 43
Transcriptional regulation of hemopoiesis
Barreda, D. R., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00035-0 · Cited by 45
Important roles of reversible acetylation in the function of hematopoietic transcription factors
Huo, X., & Zhang, J. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00340.x · Cited by 42
“first reported that GATA-1 could be acetylated by the transcriptional cofactor CBP/p300 in vivo and in vitro and the acetylation directly stimulated GATA-1-dependent transcription [12].”
BackgroundChen, L.-C., Chen, B., Chang, J.-M., & Chang, W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.04.003 · Cited by 41
Transcriptional Mechanisms by the Coregulator MAML1
Ribeiro, M. J., & Wallberg, A. E. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789630543 · Cited by 43
Critical Role of Histone Acetylation by p300 in Human Placental 11β-HSD2 Expression
Li, J., Wang, W., Liu, C., Wang, W., Li, W., Shu, Q., Chen, Z., & Sun, K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4291 · Cited by 44
“For the p300 overexpression study, the cytotrophoblasts after plating overnight were transfected with 1 g of the pCI vector carrying the full-length p300 (pCI-p300, courtesy of Dr Joan Boyes, Medical Research Council Clinical Sciences Center, Hammersmith Hospital, London, United Kingdom) (18) or equal quantity of empt…”
MethodCastaño, E., Groß, P., Wang, Z., Roeder, R. G., & Oelgeschläger, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140202297 · Cited by 39
Sumoylation and Acetylation Play Opposite Roles in the Transactivation of PLAG1 and PLAGL2*
Zheng, G., & Yang, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504334200 · Cited by 39
Shen, W.-F., Chrobak, D., Krishnan, K., Lawrence, H. J., & Largman, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404132200 · Cited by 42
Hirai, M., Ono, K., Morimoto, T., Kawamura, T., Wada, H., Kita, T., & Hasegawa, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401737200 · Cited by 45
YY1 and GATA-1 Interaction Modulate the Chicken 3′-Side α-Globin Enhancer Activity
Rincón‐Arano, H., Valadéz-Graham, V., Guerrero, G., Escamilla-Del-Arenal, M., & Targa, F. R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.040 · Cited by 40
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
Geng, X., Wang, C., Gao, X., Chowdhury, P., Weiss, J., Villegas, J. A., Saed, B., Perera, T., Hu, Y., Reneau, J. C., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00745-y · Cited by 40
“However, we were most intrigued by p300, as post-translational acetylation of many GATA family members has been variously associated with regulating protein stability, protein-protein interactions, and DNA binding affinity [52, 63], and previous studies further suggest a regulatory role for post-translational acetylat…”
Park, B.-K., Park, S., Park, J., Park, M. C., Min, T. S., & Jin, M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.05.007 · Cited by 42
“GATA-1 undergoes multiple post-translationalmodifications, including acetylation, phosphorylation and SUMOylation,which increase its DNA binding activity and translocation to the nuclear region, meanwhile, simultaneously up-regulating transactivation of theGATA-1 target gene [42],whereas, acetylated and phosphorylated…”
BackgroundQiu, Y., Guo, M. A., Huang, S., & Stein, R. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307577200 · Cited by 38
Electrospray ionization and matrix-assisted laser desorption ionization mass spectrometry
Bakhtiar, R., & Nelson, R. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00317-2 · Cited by 50
Long-distance chromatin mechanisms controlling tissue-specific gene locus activation
Bonifer, C. (1999) · Gene · doi:10.1016/s0378-1119(99)00340-6 · Cited by 46
Characterization of transcription factors by mass spectrometry and the role of SELDI‐MS
Forde, C. E., & McCutchen‐Maloney, S. L. (2002) · Mass Spectrometry Reviews · doi:10.1002/mas.10040 · Cited by 37
Stable Chromatin Binding Prevents FoxA Acetylation, Preserving FoxA Chromatin Remodeling
Kohler, S., & Cirillo, L. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063149 · Cited by 37
The Rubinstein–Taybi syndrome: modeling mental impairment in the mouse
Barco, Á. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00320.x · Cited by 37
“4 To catalyze the transfer of acetyl groups to lysine residues in proteins other than histones, such as the tumor sup- pressors p53 and pRb, diverse transcription factors, and components of the RNApol II complex (Boyes et al. 1998; Chan et al. 2001; Gu & Roeder 1997; Hung et al. 2001).”
BackgroundEzoe, S., Matsumura, I., Gale, K. B., Satoh, Y., Ishikawa, J., Mizuki, M., Takahashi, S., Minegishi, N., Nakajima, K., Yamamoto, M. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413461200 · Cited by 38
“Nuclear FGF Receptor‐1 and CREB Binding Protein: An Integrative Signaling Module”
Stachowiak, M. K., Birkaya, B. G., Aletta, J. M., Narla, S. T., Benson, C. A., Decker, B., & Stachowiak, E. K. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24879 · Cited by 42
A Paradoxical Mutant GATA Factor
Muro‐Pastor, M. I., Strauss, J., Ramón, A., & Scazzocchio, C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.393-405.2004 · Cited by 42
“The DNA-binding domain of both chicken and murine GATA-1 and murine GATA-3 can be acetylated by p300/CBP in vitro and in vivo (9, 29, 67).”
BackgroundChromatin modifiers and tumor suppression
Klochendler‐Yeivin, A., & Yaniv, M. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00021-x · Cited by 43
LRH-1/NR5A2 cooperates with GATA factors to regulate inhibin α-subunit promoter activity
Robert, N. M., Miyamoto, Y., Taniguchi, H., & Viger, R. S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.06.011 · Cited by 41
Galasinski, S. K., Lively, T. N., de Barron, A. G., & Goodrich, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1923-1930.2000 · Cited by 35
“Acetylation of GATA-1 by p300 stimulates DNA binding and may alter the conformation of the GATA-1–DNA complex (5).”
BackgroundPan, P., Qin, G., Wang, B., Yu, H., Chen, J., Liu, J., Bing, K., Shen, J., Ren, D., Zhao, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4362 · Cited by 34
“The histone acetyltransferase CREB-binding protein and p300 (CBP/p300) were the first described regulators to promote GATA1 DNA binding or chromatin occupancy via acetylation of lysine residues near the finger domain of GATA1 and further facilitate the recruitment of bromodomain proteins to the chromatin (19, 35, 36).”
BackgroundDeregulated transcription factors in leukemia
Shima, Y., & Kitabayashi, I. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0905-9 · Cited by 37
“CBP acetylates histone and non-histone proteins, including p53 [58], GATA-1 [ 59 ] and c-Myb [60], and activates transcription factors essential for hematopoiesis, such as AML1, RARa and PU.1.”
BackgroundKamitani, H., Kameda, H., Kelavkar, U. P., & Eling, T. E. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01155-8 · Cited by 34
Morceau, F., Dupont, C., Palissot, V., Borde-Chiché, P., Trentesaux, C., Dicato, M. A., & Diederich, M. F. (2000) · Leukemia · doi:10.1038/sj.leu.2401890 · Cited by 36
Eosinophil-specific Regulation of gp91 Gene Expression by Transcription Factors GATA-1 and GATA-2
Yang, D., Suzuki, S., Hao, L. J., Fujii, Y., Yamauchi, A., Yamamoto, M., Nakamura, M., & Kumatori, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9425 · Cited by 33
Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells
Jiang, S., Dowdy, S. C., Meng, X. W., Wang, Z., Jones, M. B., Podratz, K. C., & Jiang, S. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.01.012 · Cited by 35
“However, it appears that these agents cause hyperacetylation of a variety of proteins, the subject of recent studies [22,23].”
BackgroundYu, Y., Chiang, Y.-J., & Yen, J. J. Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200924200 · Cited by 39
Fax, P., Lehmkühler, O., Kühn, C., Esche, H., & Brockmann, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004626200 · Cited by 40
HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
Wang, J., Yun, F., Sui, J., Liang, W., Shen, D., & Zhang, Q. (2022) · Biomedicines · doi:10.3390/biomedicines11010088 · Cited by 37
“Abbreviations Abbreviation Full Name 4-PBA Sodium Phenylbutyrate Acss1 Acyl-CoA Synthetase Short-Chain Family Member 1 AKT Protein Kinase B ARID1A (A+T)-Rich Interaction Domain 1A ARNT Aryl Hydrocarbon Receptor Nuclear Translocator ASD Autism Spectrum Disorder ASS1 Argininosuccinate Synthase 1 ATAT1 α-tubulin N-acetyl…”
Zhang, Q., Gu, J., Gong, P., Wang, X., Tu, S., Bi, L., Yu, Z., Zhang, Z., Cui, Z., Wei, H., et al. (2013) · FEBS Journal · doi:10.1111/febs.12216 · Cited by 39
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers
Bauman, J. E., Shaheen, M., Verschraegen, C. F., Belinsky, S. A., Fekrazad, M. H., Lee, F.-C., Rabinowitz, I., Ravindranathan, M., & Jones, D. V. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.03.001 · Cited by 33
“HDACs remove acetyl groups from the histone lysine residues (as well as other nonhistone proteins), leading to the formation of a condensed and transcriptionally silenced chromatin.”
BackgroundInfluentialComprehensive Profiling of Lysine Acetylome in Baculovirus Infected Silkworm (Bombyx mori) Cells
Hu, D., Xue, S., Zhao, C., Wei, M., Yan, H., Quan, Y., & Yu, W. (2018) · PROTEOMICS · doi:10.1002/pmic.201700133 · Cited by 34
Towatari, M., Cirò, M., Ottolenghi, S., Tsuzuki, S., & Enver, T. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200345 · Cited by 37
Zhao, Q., Cumming, H. E., Cerruti, L., Cunningham, J. M., & Jane, S. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405129200 · Cited by 34
REDK, a novel human regulatory erythroid kinase
Lord, K. A., Creasy, C. L., King, A. G., King, C., Burns, B. M., Lee, J. C., & Dillon, S. B. (2000) · Blood · doi:10.1182/blood.v95.9.2838.009k29_2838_2846 · Cited by 34
Feng, D.-X., & Kan, Y. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502041102 · Cited by 32
Mechanism of RNA Polymerase I Transcription
Comai, L. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)67005-7 · Cited by 35
Functions of PIT1 in GATA2-dependent transactivation of the thyrotropin β promoter
Kashiwabara, Y., Sasaki, S., Matsushita, A., Nagayama, K., Ohba, K., Iwaki, H., Matsunaga, H., Suzuki, S., Misawa, H., Ishizuka, K., et al. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0099 · Cited by 31
“Zn finger domains, but not the N- or C-terminal regions of GATA1 and 3, have high homology with those of GATA2 (Fig. 2A; Boyes et al. 1998).”
BackgroundKolchanov, N. A., Ananko, E. A., Kolpakov, F., Podkolodnaya, O. A., Ignat’eva, E. V., Goryachkovskaya, T. N., & Степаненко, И. Л. (2000) · Molecular Biology · doi:10.1007/bf02759554 · Cited by 36
Glucocorticoid effects on gene expression
Kino, T., & Chrousos, G. P. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80017-3 · Cited by 38
The beta‐globin locus control region versus gene therapy vectors: a struggle for expression
Ellis, J., & Pannell, D. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.590103.x · Cited by 30
Layon, M. E., Ackley, C. J., West, R. J., & Lowrey, C. H. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.094 · Cited by 34
Sánchez-Molina, S., Oliva, J. L., García-Vargas, S., Valls, E., Rojas, J. M., & Martínez‐Balbás, M. A. (2006) · Biochemical Journal · doi:10.1042/bj20060052 · Cited by 34
“The global co-activators CBP and p300 not only exhibit histone acetyltransferase activity (3, 4), but they also acetylate non-histone proteins, such as transcription factors (5-10), thereby highlighting the potential importance of HAT activity in CBP/p300 function.”
BackgroundAlternative TFAP2A isoforms have distinct activities in breast cancer
Berlato, C., Chan, K. V., Price, A. M., Canosa, M., Scibetta, A. G., & Hurst, H. C. (2011) · Breast Cancer Research · doi:10.1186/bcr2838 · Cited by 30
“Other plasmids were: pCI-p300 [20], pRc/CMV CBP [21], pcDNA3-CITED2 [11], pcDNA3-CITED4 [10], pSG5 sumo1 ΔHSTV and pSG5 sumo2 ΔVY generated by PCR, pSG5 ubc9 [15], pSG5 Ubc9 C93S [15].”
LIU, C., Lu, J., Tan, J., Li, L., & Huang, B. (2004) · Cytokine · doi:10.1016/j.cyto.2004.02.003 · Cited by 32
Rusconi, F., Guillonneau, F., & Praseuth, D. (2002) · Mass Spectrometry Reviews · doi:10.1002/mas.10036 · Cited by 30
Avian erythroleukemia: a model for corepressor function in cancer
RIETVELD, L. E. G., Caldenhoven, E., & Stunnenberg, H. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204335 · Cited by 33
“It was shown by Boyes and coworkers that acetylation of GATA1 potentiated its transcriptional activity and was essential for erythroid di erentiation (Boyes et al., 1998; Hung et al., 1999).”
BackgroundRequirement of Two NFATc4 Transactivation Domains for CBP Potentiation
Yang, T. T. C., Davis, R. J., & Chow, C.-W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102961200 · Cited by 33
p300/CBP Acts as a Coactivator of the Cone–Rod Homeobox Transcription Factor
Yanagi, Y., Masuhiro, Y., Mori, M., Yanagisawa, J., & Kato, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2304 · Cited by 29
Diesch, J., Pannérer, M.-M. L., Winkler, R., Casquero, R., Muhar, M., van der Garde, M., Maher, M., Herraez, C. M., Bech‐Serra, J. J., Fellner, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26258-z · Cited by 28
Ski Negatively Regulates Erythroid Differentiation through Its Interaction with GATA1
Ueki, N., Zhang, L., & Hayman, M. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10118-10125.2004 · Cited by 33
“For instance, it is reported that activity of GATA1 is regulated by protein modification such as acetylation and phosphorylation and that these modifications enhance GATA1 DNA binding ( 3 , 32).”
BackgroundHe, T., Hong, S. Y., Huang, L., Xue, W., Yu, Z., Kwon, H., Kirk, M., Ding, S., Su, K., & Zhang, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176289 · Cited by 28
GATA-1 Self-association Controls Erythroid Development in Vivo
Shimizu, R., Trainor, C. D., Nishikawa, K., Kobayashi, M., Ohneda, K., & Yamamoto, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701936200 · Cited by 31
Gachon, F., Devaux, C. A., & Mesnard, J.-M. (2002) · Virology · doi:10.1006/viro.2002.1501 · Cited by 32
“1) contains lysine residues that are flanked by sequences conform to the consensus for the acetylation of nonhistone proteins (K/RXKK) suggested from studies of p53 and GATA-1 acetylation (Gu and Roeder, 1997; Boyes et al., 1998).”
A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3
Nakayama, K., Kim, K., & Miyajima, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf596 · Cited by 30
Critical Role for Lysine 133 in the Nuclear Ubiquitin-mediated Degradation of MyoD
Batonnet‐Pichon, S., Leibovitch, M.-P., Tintignac, L. A. J., & Leibovitch, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310315200 · Cited by 28
Insight Into the Tumor Suppressor Function of CBP Through the Viral Oncoprotein Tax
Orden, K. V., & Nyborg, J. K. (2001) · Gene Expression · doi:10.3727/000000001783992678 · Cited by 29
“ATL is characterized clinically by skin lesions mias (1,65,72,75).”
BackgroundGregoricchio, S., Polit, L., Esposito, M., Berthelet, J., Delestré, L., Evanno, E., Diop, M., Gallais, I., Aleth, H., Poplineau, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac613 · Cited by 27
“Previous reports proposed that SPI1, by binding to GATA1, impedes histone or GATA1 acetylation, which is required for the stabilization of GATA1 binding at the chromatin (72,73).”
BackgroundLakshmanan, M., & Shaheer, K. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01241-5 · Cited by 27
Exploring cellular memory molecules marking competent and active transcriptions
Xin, L., Zhou, G., Song, W., Wu, X., Wei, G., Hao, D., Lv, X., Liu, D., & Liang, C. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-31 · Cited by 34
“Previous studies have shown that GATA-1 is involved in regulating transcription by undergoing modifications such as acetylation, phosphorylation and sumoylation, without the recruitment of other partners [17-19].”
BackgroundAdam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Schoonbroodt, S., Goffin, V., Nguyên, T. L.-A., Gloire, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6890.2004 · Cited by 27
“For some of these transcription factors—such as p53 (21) and GATA-1 ( 7 )—acetylation has been shown to lead to increased DNA binding and transactivation capacities.”
The Multifunctional Role of E1A in the Transcriptional Regulation of CREB/CBP-Dependent Target Genes
Brockmann, D., & Esche, H. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05597-7_4 · Cited by 30
Jiang, W., Nordeen, S. K., & Kadonaga, J. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000713200 · Cited by 27
Gcn5p-dependent acetylation induces degradation of the meiotic transcriptional repressor Ume6p
Mallory, M. J., Law, M. J., Sterner, D. E., Berger, S. L., & Strich, R. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0536 · Cited by 29
“For example, acetylation of p53 and GATA-1 by p300 increases their respective DNA-binding activities (Gu et al., 1993; Boyes et al., 1998).”
Antiproliferative effect of trichostatin a and hc-toxin in T47D Human breast cancer cells
Joung, K. E., Kim, D., & Sheen, Y. Y. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980164 · Cited by 26
Taghiyev, A. F., Guseva, N. V., Sturm, M. T., Rokhlin, O. W., & Cohen, M. B. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.4.1615 · Cited by 30
Qamar, I., Park, E., Gong, E., Lee, H. J., & Lee, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900896200 · Cited by 26
Yamamoto, S., Yamano, T., Tanaka, M., Hoon, D. S. �., Takao, S., Morishita, R., Aikou, T., & Kaneda, Y. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700551 · Cited by 25
Lührs, H., Hock, R., Schauber, J., Weihrauch, M., Harrer, M., Melcher, R., Scheppach, W. M., Bustin, M., & Menzel, T. (2001) · International Journal of Cancer · doi:10.1002/ijc.10098 · Cited by 25
Marcello, A., Massimi, P., Banks, L., & Giacca, M. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9090-9098.2000 · Cited by 25
“One of the factors recently identified as binding to the Nterminal domain of E2 is the human transcriptional coactivator p300 homologue CBP (35), a protein with histone acetyltransferase (2, 53) and factor acetyltransfrase (7, 18, 41, 44, 51) activities.”
BackgroundYamamoto, H., Kihara‐Negishi, F., Yamada, T., Suzuki, M., Nakano, T., & Oikawa, T. (2002) · PubMed · Cited by 29
Martín, J. F., Liras, P., & Sánchez, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.630694 · Cited by 25
Hou, L., Li, B., Ding, D., Kang, L., & Wang, X. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008176 · Cited by 27
Diederich, M. F. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000212 · Cited by 24
“Indeed, the necessity of GATA-1 acetylation for its transcriptional activity in vivo, without affecting its interaction with FOG-1, CBP, or GATA-1 was previously reported (39-41).”
BackgroundChromatin organisation and human disease
Urnov, F. D., & Wolffe, A. P. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.5.665 · Cited by 26
“For instance, acetylation of the transcription factors GATA-1, EKLF and HNF-4 by the p300/CBP HAT upregulates transcription [92-94], whereas acetylation of a HAT called ACTR by the very same p300/CBP attenuates oestrogen receptor-driven transcription [89].”
Background
Metadata
- Authors
- Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V.
- Affiliations
- Institute of Cancer Research (GB)
- Hammersmith Hospital (GB)
- National Institutes of Health (US)
- Corresponding author
- Boyes, Joan
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6711
- Pages
- 594-598
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1626483287
- Cited by
- 694
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 14 · 2013: 14 · 2012: 15
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- GATA-1, histone acetylation, CBP/p300, transcriptional coactivator, histone acetyltransferase, protein conformational change, erythroid differentiation, acetylation sites
- MeSH terms
- Acetylation, Amino Acid Sequence, Animals, Binding Sites, Chickens, DNA, DNA-Binding Proteins, Lysine, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Mass Spectrometry, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Trans-Activators, Zinc Fingers, 3T3 Cells, E1A-Associated p300 Protein, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.